tiprankstipranks
Advertisement
Advertisement

CHRO Stock Latest News

Roche’s Genentech announces $750M manufacturing expansion in Hillsboro, GA
The FlyRoche’s Genentech announces $750M manufacturing expansion in Hillsboro, GA
23h ago
CHRO
Ideaya Biosciences enters IDE892 collaboration with Genentech
PremiumThe Fly
Ideaya Biosciences enters IDE892 collaboration with Genentech
2d ago
CHRO
IDYA
Roche upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Roche upgraded to Overweight from Equal Weight at Morgan Stanley
14d ago
CHRO
Roche expands cyclospora testing portfolio to support US public health response
PremiumThe Fly
Roche expands cyclospora testing portfolio to support US public health response
15d ago
CHRO
Labcorp launches FDA-approved PTEN companion diagnostic for prostate cancer
PremiumThe Fly
Labcorp launches FDA-approved PTEN companion diagnostic for prostate cancer
17d ago
LH
Genprex announces collaboration with Roche Diagnostics
PremiumThe FlyGenprex announces collaboration with Roche Diagnostics
18d ago
CHRO
GNPX
Roche announces EMA’s CHMP recommended approval of Susvimo
Premium
The Fly
Roche announces EMA’s CHMP recommended approval of Susvimo
28d ago
CHRO
Roche receives FDA 510(k) clearance for cobas BV/CV assay
Premium
The Fly
Roche receives FDA 510(k) clearance for cobas BV/CV assay
28d ago
CHRO
Roche confirms FY26 outlook
PremiumThe Fly
Roche confirms FY26 outlook
29d ago
CHRO
Roche reports 1H group sales CHF 30.4B vs. CHF 30.9B last year
PremiumThe Fly
Roche reports 1H group sales CHF 30.4B vs. CHF 30.9B last year
29d ago
CHRO
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
PremiumThe Fly
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
1M ago
XE
AAL
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
PremiumThe Fly
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
1M ago
AZN
BMY
MaxCyte enters technology license partnership with Genentech
PremiumThe FlyMaxCyte enters technology license partnership with Genentech
1M ago
CHRO
MXCT
Roche names Dan Malarek as President and CEO of Roche Diagnostics North America
Premium
The Fly
Roche names Dan Malarek as President and CEO of Roche Diagnostics North America
1M ago
CHRO
Genentech granted priority review for Gazyva sBLA by FDA
Premium
The Fly
Genentech granted priority review for Gazyva sBLA by FDA
1M ago
CHRO
Nurix Therapeutics price target raised to $34 from $32 at Truist
PremiumThe Fly
Nurix Therapeutics price target raised to $34 from $32 at Truist
1M ago
CHRO
NRIX
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
PremiumThe Fly
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
1M ago
CHRO
NRIX
Roche receives CE Mark for blood test to identify tuberculosis infection
PremiumThe Fly
Roche receives CE Mark for blood test to identify tuberculosis infection
1M ago
CHRO
Roche downgraded to Hold from Buy at HSBC
PremiumThe Fly
Roche downgraded to Hold from Buy at HSBC
2M ago
CHRO
Genentech announces Krascendo 1 study met primary, key secondary endpoint
PremiumThe FlyGenentech announces Krascendo 1 study met primary, key secondary endpoint
2M ago
CHRO
AI Daily: Amazon’s AWS commits $1B toward new unit
Premium
The Fly
AI Daily: Amazon’s AWS commits $1B toward new unit
2M ago
AZN
BMY
Anthropic takes aim at pharma industry with Claude Science, STAT reports
Premium
The Fly
Anthropic takes aim at pharma industry with Claude Science, STAT reports
2M ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >